Teladoc Health Reports Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Teladoc (TDOC) Shares Down 7% Following Q4 Results and Mixed Outlook
February 22, 2022 5:37 PM ESTTeladoc (NYSE: TDOC) shares were trading around 7% lower after-hours despite the company's reported Q4 results, with EPS of ($0.07) coming in better than the Street estimate of ($0.56). Revenue grew 45% year-over-year to $554.2 million, compared to the Street estimate of $546.6 million. Access fees and visit fee revenues grew 51% and... More
Teladoc (TDOC) Tops Q4 EPS, Revenues; Provides Mixed Outlook
February 22, 2022 4:13 PM ESTTeladoc (NYSE: TDOC) reported Q4 EPS of ($0.07), $0.49 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $554.2 million versus the consensus estimate of $546.6 million.
GUIDANCE:
Teladoc sees FY2022 revenue of $2.55-2.65 billion, versus the consensus of $2.57... More
